GLMD Stock Summary and Trading Ideas (Galmed Pharmaceuticals Ltd. - | NASDAQ:GLMD)

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.

Galmed Pharmaceuticals Ltd. - trades on the NASDAQ stock market under the symbol GLMD.

As of September 9, 2026, GLMD stock price climbed to $4.63 with 102,843 million shares trading.

GLMD has a beta of 2.83, meaning it tends to be more sensitive to market movements. GLMD has a correlation of 0.19 to the broad based SPY ETF.

GLMD has a market cap of $4.95 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, GLMD traded as high as $190.40 and as low as $3.29.

GLMD has underperformed the market in the last year with a return of -57.8%, while SPY returned +18.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in GLMD shares. However, GLMD has outperformed the market in the last 3 month and 2 week periods, returning +23.3% and +7.5%, while SPY returned +3.4% and -0.5%, respectively. This indicates GLMD has been having a stronger performance recently.

GLMD support price is $3.56 and resistance is $4.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GLMD shares will trade within this expected range on the day.